Fluoptics - Fluorescent Imaging against Cancer

Small to big animals in vivo molecular imaging

Fluoptics provides molecular probes and systems for in vivo optical imaging in preclinical applications on large and small animals. This combined solution helps understanding diseases mechanisms and developping new therapies.

Fluobeam^® Imaging System
The only hand held preclinical fluorescence reflectance real time imager working in ambient light.
Compatible with all major optical probes in the near infra red.

Innovative Solution
Portable
Works in ambient light
Real time imaging
From small to big animals
Easy to use
Affordable

Two systems available:

Fluobeam^®700
λEx : 690nm
λEm : > 700nm

Fluobeam^®800
- λEx : 785nm
- λEm : > 800nm

NIR molecular probes

AngioLone^®
Probe targeting angiogenesis ready for labeling

AngioStamp^®AngioStamp^® is a NIR fluorescence imaging agent targeting the ανβ3 integrin. The ανβ3 integrin is overexpressed at the surface of activated endothelial cells during angiogenesis and in various types of tumor cells.

AngioStamp^® shows an original structure with two distinct faces: the first allows the recognition of the ανβ3 integrins and the second is used for fluorescent labeling.

AngioStamp^® enable in vivo imaging of:
- neovessels during tumor angiogenesis
- ανβ3 positive tumor cells and metastisis

SentiDye^®700 - SentiDye^® 800
SentiDye^® are NIR fluorescence lipidic nanoparticles with a high chemical stablity that display improved stable optical properties in comparison to the free dye in solution.

Sentidye^® enables in vivo imaging of vascular network, lymph nodes and tumors via passive accumulation.Sentidye® is available in two versions.

For further information and/or a demo of the Fluoptics products, please contact us at info@touchdown-bioinnovation.com, our visit www.fluoptics.com.